Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -25,283 | -93,922 |
| Depreciation Amortization | 356 | 1,745 |
| Accounts payable and accrued liabilities | 1,362 | N/A |
| Other Working Capital | -4,010 | 1,465 |
| Other Operating Activity | 1,146 | 9,494 |
| Operating Cash Flow | $-26,429 | $-81,218 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -162 | -1,404 |
| Investing Cash Flow | $-162 | $-1,404 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 26,591 | 82,622 |
| Financing Cash Flow | $26,591 | $82,622 |
| Net Cash Flow | $0 | $0 |
| Free Cash Flow | ||
| Operating Cash Flow | -26,429 | -81,218 |
| Capital Expenditure | -162 | N/A |
| Free Cash Flow | -26,591 | -81,218 |